Stereotactic body radiotherapy for treating lung cancer with a leadless pacemaker: A case report

This case emphasizes the critical need for identifying LLPMs prior to treatment and the importance of tailored radiotherapy plans to prevent device malfunction. The increasing use of these devices necessitates adherence to guidelines which recommend cumulative radiation doses of <5 Gy. Consequently, a thorough patient history and meticulous imaging review are required since identifying LLPMs on computed tomography can be challenging. Furthermore, effective SBRT in patients with lung cancer and LLPMs requires careful planning to ensure safety and therapeutic success. This case provides valuable insights for radiation oncologists, advocating for diligent pretreatment evaluation and customized radiation strategies in the context of evolving cardiac implant technologies.